Product NDC: | 42364-4501 |
Proprietary Name: | Cystex |
Non Proprietary Name: | Methenamine, Sodium Salicylate |
Active Ingredient(s): | 162; 162.5 mg/1; mg/1 & nbsp; Methenamine, Sodium Salicylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42364-4501 |
Labeler Name: | DSE Healthcare Solutions, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120401 |
Package NDC: | 42364-4501-2 |
Package Description: | 100 TABLET in 1 BOTTLE (42364-4501-2) |
NDC Code | 42364-4501-2 |
Proprietary Name | Cystex |
Package Description | 100 TABLET in 1 BOTTLE (42364-4501-2) |
Product NDC | 42364-4501 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Methenamine, Sodium Salicylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120401 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | DSE Healthcare Solutions, LLC |
Substance Name | METHENAMINE; SODIUM SALICYLATE |
Strength Number | 162; 162.5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |